| Dr Wadah Atassi, MD | |
|
2701 W 68th Street, Professional Pavilion 4 South, Chicago, IL 60629-1813 | |
| (773) 735-4884 | |
| (773) 735-2625 |
| Full Name | Dr Wadah Atassi |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 39 Years |
| Location | 2701 W 68th Street, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336125327 | NPI | - | NPPES |
| 01615184 | Other | IL | BCBS |
| 01621679 | Other | IL | BCBS OF IL |
| 036081178 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 036081178 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fmc - Southside Dialysis Center | Chicago, IL | Dialysis facility |
| Affiliated Dialysis Centers | Oak park, IL | Dialysis facility |
| Concerto Dialysis | Crestwood, IL | Dialysis facility |
| Fmc - Dupage Peritoneal Dialysis Services | Elmhurst, IL | Dialysis facility |
| Holy Cross Hospital | Chicago, IL | Hospital |
| Osf Little Company Of Mary Medical Center | Evergreen park, IL | Hospital |
| St Bernard Hospital | Chicago, IL | Hospital |
| South Shore Hospital | Chicago, IL | Hospital |
| Ingalls Memorial Hospital | Harvey, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nephrology Associates Of Northern Illinois Ltd | 2163328675 | 97 |
News Archive
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management.
Students competing for resources in the classroom while discounting each others' success are less likely to earn top grades than students who work together toward goals and share their success, according to an analysis of 80 years of research.
› Verified 8 days ago
| Entity Name | Nephrology Associates Of Northern Illinois Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124069182 PECOS PAC ID: 2163328675 Enrollment ID: O20031208000313 |
News Archive
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management.
Students competing for resources in the classroom while discounting each others' success are less likely to earn top grades than students who work together toward goals and share their success, according to an analysis of 80 years of research.
› Verified 8 days ago
| Entity Name | Willow Springs Surgery Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1467429233 PECOS PAC ID: 5092783712 Enrollment ID: O20040921000585 |
News Archive
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management.
Students competing for resources in the classroom while discounting each others' success are less likely to earn top grades than students who work together toward goals and share their success, according to an analysis of 80 years of research.
› Verified 8 days ago
| Entity Name | Kidney And Hypertension Associates Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265511984 PECOS PAC ID: 3577595545 Enrollment ID: O20050910000077 |
News Archive
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management.
Students competing for resources in the classroom while discounting each others' success are less likely to earn top grades than students who work together toward goals and share their success, according to an analysis of 80 years of research.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wadah Atassi, MD 120 W 22nd St Ste 200, Oak Brook, IL 60523-1563 Ph: (630) 573-5000 | Dr Wadah Atassi, MD 2701 W 68th Street, Professional Pavilion 4 South, Chicago, IL 60629-1813 Ph: (773) 735-4884 |
News Archive
Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.
Atrial fibrillation patients who use the drug, warfarin, to prevent harmful blood clots from forming in their hearts to lower risk of stroke are at higher risk of developing dementia than patients who use warfarin for non-atrial fibrillation conditions, according to a new study from the Intermountain Medical Center Heart Institute.
RNAi-based therapeutics company Benitec Biopharma Limited today announced the selection of the University of California, San Diego, Health Sciences as the second site for its upcoming phase I/II first-in-man trial for TT-034 in Hepatitis C infections.
Early diagnosis and treatment that quickly achieves seizure freedom with nominal side effects is the key goal to epilepsy management.
Students competing for resources in the classroom while discounting each others' success are less likely to earn top grades than students who work together toward goals and share their success, according to an analysis of 80 years of research.
› Verified 8 days ago
Dr. Sorin C Danciu, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3134 N Clark St, Chicago, IL 60657 Phone: 773-880-9722 | |
Anoopa A. Koshy, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 259 E Erie St Ste 2200, Chicago, IL 60611 Phone: 312-926-6000 | |
William Edmond Gerardi, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 3730 N Lake Shore Dr, Apartment 2a, Chicago, IL 60613 Phone: 773-244-3060 | |
Suparna Dutta, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1700 W Van Buren St, Suite 500, Chicago, IL 60612 Phone: 312-942-4200 Fax: 312-942-3568 | |
Alexandra Dumitrescu, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Dr. Mitesh Mahesh Kabadi, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St Ste 1159, Chicago, IL 60612 Phone: 312-942-5020 | |
Dr. Marta Batus, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1725 W Harrison St, Suite 809, Chicago, IL 60612 Phone: 312-563-2487 Fax: 312-942-3192 |